Syngene International Ltd - 539268 - Record Date For AGM As July 14, 2021
Record date fixed as Wednesday, July 14, 2021 for the purpose of holding the 28th Annual General Meeting27-04-2021
27-04-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Allotment
We hereby inform that the Board of Directors of the Company at its meeting held today i.e. April 27, 2021, has allotted 7,96,500 equity shares to the Syngene Employee Welfare Trust under the Syngene Restricted Stock Unit Long Term Incentive Plan FY 2020. Consequent to the aforesaid allotment, the paid-up share capital of the Company has increased from Rs. 4,00,00,00,000/- (40,00,00,000 Equity Shares of Rs. 10/- each) to Rs. 4,00,79,65,000 /- (40,07,96,500 Equity Shares of Rs. 10/- each).27-04-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentation
This has reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Investor Presentation for the quarter and year ended March 31, 2021. The Company will use this presentation for any meeting scheduled with analysts or institutional investors up to June 30, 2021.27-04-2021
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
This has reference to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the press release titled 'Syngene reports revenue from operations growth of 13% in the fourth quarter; 12% for the full year'.27-04-2021
Syngene International Ltd - 539268 - Outcome Of The Board Meeting
Approved Audited financial results (consolidated and standalone) as per Indian Accounting Standard (Ind-AS) for the quarter and year ended March 31, 2021. A copy of the audited financial results along with the Auditors' Report and a declaration under Regulation 33(3)(d) of SEBI (LODR) Regulations, 2015 is enclosed herewith27-04-2021
Syngene International Ltd - 539268 - Sub: Outcome Of The Board Meeting
Outcome of the Board Meeting27-04-2021
Syngene extends research collaboration with Bristol Myers Squibb
Tie up to extend through the end of 203027-04-2021
Syngene International Ltd - 539268 - Initial Disclosure To Be Made By An Entity Identified As A Large Corporate.
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.24-04-2021
Syngene International Ltd - 539268 - Board to consider FY21 results & Final Dividend on April 27, 2021
With reference to the earlier letter dated April 06, 2021 regarding a meeting of the Board of Directors has been scheduled on April 27, 2021, Syngene International Ltd has now informed BSE that the meeting will be held, inter alia, to consider and approve the Audited Standalone and Consolidated financial results for the quarter and year ended March 31, 2021 and consider proposal for recommendation of final dividend, if any, for the financial year 2020-21.23-04-2021
Syngene International Ltd - 539268 - Update on board meeting
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2021 ,inter alia, to consider and approve Update on board meeting22-04-2021